Results 1 to 10 of about 389,573 (268)
Human Vaccines & Immunotherapeutics, 2022 Group B streptococcus (Streptococcus agalactiae, GBS) is an important cause of life-threatening disease in newborns. Pregnant women colonized with GBS can transmit the bacteria to the developing fetus, as well as to their neonates during or after ...
Judith Absalon +6 more
doaj +1 more source
Lipopeptides for Vaccine Development [PDF]
Bioconjugate Chemistry, 2021 The development of lipopeptides (lipidated peptides) for vaccines is discussed, including their role as antigens and/or adjuvants. Distinct classes of lipopeptide architectures are covered including simple linear and ligated constructs and lipid core peptides.
openaire +3 more sources
Peptides for Vaccine Development [PDF]
ACS Applied Bio Materials, 2022 This review discusses peptide epitopes used as antigens in the development of vaccines in clinical trials as well as future vaccine candidates. It covers peptides used in potential immunotherapies for infectious diseases including SARS-CoV-2, influenza, hepatitis B and C, HIV, malaria, and others.
openaire +2 more sources
npj Vaccines, 2023 Group B streptococcus (GBS) is a leading cause of neonatal morbidity and mortality worldwide. Development of a maternal vaccine to protect newborns through placentally transferred antibody is considered feasible based on the well-established relationship
Alexandre Esadze +10 more
doaj +1 more source
COVID-19 Vaccine Development to Vaccination
Journal of Nepal Health Research Council, 2021 In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine ...
Ashok Pandey +2 more
openaire +2 more sources
Human Vaccines & Immunotherapeutics, 2021 There is an urgent need for an accessible and low-cost COVID-19 vaccine suitable for low- and middle-income countries. Here, we report on the development of a SARS-CoV-2 receptor-binding domain (RBD) protein, expressed at high levels in yeast (Pichia ...
Jeroen Pollet +19 more
doaj +1 more source
Transforming Vaccine Development
Seminars in Immunology, 2020 The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines which are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine ...
Steve Black +4 more
openaire +4 more sources
Development of Varicella Vaccine [PDF]
The Journal of Infectious Diseases, 2008 The Oka strain of varicella-zoster virus (VZV) was first isolated from vesicles of an otherwise healthy 3-year-old boy with typical varicella. The virus was passaged 11 times in human embryonic lung fibroblasts at 34 degrees C and 12 times in guinea pig embryo fibroblasts (GPEFs) at 37 degrees C.
Michiaki, Takahashi +6 more
openaire +2 more sources
Infectious Diseases and Therapy, 2023 Introduction Vaccination is a critical tool for preventing coronavirus disease 2019 (COVID-19) and influenza illnesses. Coadministration of the COVID-19 vaccine, BNT162b2, with seasonal inactivated influenza vaccine (SIIV) can provide substantial ...
Louise Murdoch +16 more
doaj +1 more source
SARS Vaccine Development [PDF]
Emerging Infectious Diseases, 2005 Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it is easy to generate; however, safety is the main concern. The spike (S) protein of SARS-CoV is the major
Shibo Jiang, Yuxian He, Shuwen Liu
openaire +3 more sources